KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Total Non-Current Liabilities (2017 - 2024)

Bionano Genomics (BNGO) has disclosed Total Non-Current Liabilities for 8 consecutive years, with $41.3 million as the latest value for Q4 2024.

  • Quarterly Total Non-Current Liabilities fell 61.53% to $41.3 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $41.3 million through Dec 2024, down 61.53% year-over-year, with the annual reading at $41.3 million for FY2024, 61.53% down from the prior year.
  • Total Non-Current Liabilities hit $41.3 million in Q4 2024 for Bionano Genomics, up from $38.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $107.4 million in Q4 2023 to a low of $17.9 million in Q3 2021.
  • Historically, Total Non-Current Liabilities has averaged $41.3 million across 5 years, with a median of $41.3 million in 2024.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 137.86% in 2023 and later tumbled 61.53% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $25.4 million in 2020, then rose by 21.87% to $30.9 million in 2021, then soared by 45.99% to $45.1 million in 2022, then skyrocketed by 137.86% to $107.4 million in 2023, then crashed by 61.53% to $41.3 million in 2024.
  • Business Quant data shows Total Non-Current Liabilities for BNGO at $41.3 million in Q4 2024, $38.5 million in Q3 2024, and $43.3 million in Q2 2024.